In this episode of “What the Health?” Mary Agnes Carey of Kaiser Health News, Sarah Karlin-Smith of Politico, Margot Sanger-Katz of The New York Times and Julie Appleby of Kaiser Health News discuss the recent extension of cost-sharing subsidies for millions of low-income beneficiaries on the Affordable Care Act’s marketplaces and the state of play on Capitol Hill and in the states concerning initiatives to lower prescription drug costs.
Una nueva encuesta revela que cada vez más los profesionales de la salud se inclinan a un sistema con un pagador único que se haga cargo de las cuentas médicas.
Growing numbers of physicians say they support a single-payer health care system, a 180-degree turn in opinion over a decade.
The change would not be expected to have much long-term effect on the number of uninsured people. But it could cause a shift in which plans are popular with marketplace customers.
Individuals who require very specialized care for their health are advised to make their case when a plan doesn’t cover their doctor.
Kaiser Health News gives readers a chance to respond, react and comment on our stories.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Sarah Kliff of Vox.com, and Margot Sanger-Katz of The New York Times discuss the state of the individual health insurance markets in the wake of the failure (for now) of Congress’s efforts to repeal and replace the Affordable Care Act.
Sen. Patty Murray questions Dr. Brett Giroir’s willingness to stand up for women’s health programs such as family planning services and teenage pregnancy prevention.
The new law will help people with chronic conditions that require multiple prescriptions cut down on their shuttles to the drug store and could improve adherence to their drugs.
Federal records show that 2,573 hospitals around the country will have their Medicare payments reduced because they have too many patients readmitted.
Court allows state attorneys general to join a pending legal challenge to keep billions in subsidies flowing to consumers and insurers, despite the Trump administration’s resistance.
The figure could be higher if President Trump ends an important consumer subsidy, which he has threatened to do. The exchange also announced that Anthem Blue Cross will pull out of Covered California and the overall individual market in 16 of the 19 regions it currently serves.
The FDA granted approval for Spinraza in late December for use on children and adults with spinal muscular atrophy. Insurance coverage is mostly focused on infants and children.
KHN examines the role of PBMs in the prescription drug-pricing pipeline.
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
A Wisconsin lawsuit alleges United Healthcare downplayed abusive sales tactics to avoid losing government bonuses.
Dr. Sanjay Mishra, the husband of CMS Administrator Seema Verma, is part of a group practice in Indiana that does not accept Medicaid payments.
In the first case of its kind in the U.S., the company was ordered to pay damages to the hospital where a patient died of an infection linked to a contaminated scope. But jurors also found the hospital negligent, and it was ordered to pay the patients’ family $1 million.
In a head-to-head comparison, several of the cheaper devices performed nearly as well as the expensive hearing aids. The study lends credence to lawmakers’ efforts to get the FDA to set standards for over-the-counter versions.
A coalition of health care providers are blocking Ohio’s law requiring health care providers to tell what non-emergency services will cost them.